600 related articles for article (PubMed ID: 19535190)
1. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
3. Oral nicorandil for prevention of cardiac death in hemodialysis patients without obstructive coronary artery disease: a propensity-matched patient analysis.
Nishimura M; Sakoda C; Murakawa M; Okamoto Y; Tokoro T; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Iwamoto N; Takahashi H; Ono T
Nephron Clin Pract; 2011; 119(4):c301-9. PubMed ID: 21934329
[TBL] [Abstract][Full Text] [Related]
4. Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia.
Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Imai R; Okino K; Iwamoto N; Takahashi H; Ono T
Nephron Clin Pract; 2009; 111(3):c212-21. PubMed ID: 19225237
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Nishimura M; Okamoto Y; Tokoro T; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Nephron Clin Pract; 2014; 126(1):24-32. PubMed ID: 24434794
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction.
Sakata Y; Nakatani D; Shimizu M; Suna S; Usami M; Matsumoto S; Hara M; Sumitsuji S; Kawano S; Iwakura K; Hamasaki T; Sato H; Nanto S; Hori M; Komuro I
J Cardiol; 2012 Jan; 59(1):14-21. PubMed ID: 21924584
[TBL] [Abstract][Full Text] [Related]
8. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
[TBL] [Abstract][Full Text] [Related]
9. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
[TBL] [Abstract][Full Text] [Related]
10. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
[TBL] [Abstract][Full Text] [Related]
11. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
12. Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction.
Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
Can J Cardiol; 2004 May; 20(6):625-9. PubMed ID: 15152293
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
[TBL] [Abstract][Full Text] [Related]
16. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
[TBL] [Abstract][Full Text] [Related]
17. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
18. First time myocardial revascularization in patients younger than 70 years. Single versus double internal mammary artery.
Di Mauro M; Iacò AL; Contini M; Vitolla G; Weltert L; Di Giammarco G; Calafiore AM
Ital Heart J; 2005 May; 6(5):390-5. PubMed ID: 15934411
[TBL] [Abstract][Full Text] [Related]
19. Effect of gradual computerized angioplasty on outcomes of patients undergoing coronary stenting.
Leibowitz D; Lotan C; Katz I; Nassar H; Boguslavsky L; Mosseri M; Jabara R; Varshitzsky B; Danenberg H; Weiss AT
Am J Cardiol; 2009 Jul; 104(2):223-6. PubMed ID: 19576351
[TBL] [Abstract][Full Text] [Related]
20. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
